BrainStorm Cell Therapeutics Provides Update on FDA Advisory Committee Meeting to Review NurOwn for the Treatment of ALS ...Middle East

NEW YORK, Sept. 27, 2023 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the outcome of the U.S. Food and Drug Administration's Cellular, Tissue and Gene Therapies...

Hence then, the article about brainstorm cell therapeutics provides update on fda advisory committee meeting to review nurown for the treatment of als was published today ( Thursday 28/09/2023 - 05:53 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BrainStorm Cell Therapeutics Provides Update on FDA Advisory Committee Meeting to Review NurOwn for the Treatment of ALS )

Also on site :

• The Russia-Africa summit 2026: What you need to know about building a multipolar world without the West
• The Pioneer Woman’s Trendy 12-Piece Chocolate Dinnerware Set Adds a Touch of Vintage Charm to Fall Tables
• Elbit Systems Awarded Approximately $200 Million in Contracts for Airborne ISTAR and Training Solutions in Asia-Pacific